Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Drug formulations for parenteral use

Drug formulations for parenteral use

US Patent 5571534 · Granted Nov 5, 1996

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medicine for Covid-19 and treatment2023
Medicine for Covid-19 and treatment2022
Medicine for Covid-19 and treatment2021
Prodrugs of 17β-HSD1-inhibitors2020
Methods for the treatment of erectile dysfunction using fispemifene2019
Prodrugs of 17.BETA.-HSD1-inhibitors2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydr2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydr2019
Hydrogel composite depot formulation2019
Method for preparing adjustably bioresorbable sol-gel derived SiO22018
Silica hydrogel composite2018
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-h2017